These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4356984)

  • 21. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway.
    Jimenez-Feltstrom J; Lundquist I; Salehi A
    Cell Tissue Res; 2005 Feb; 319(2):221-30. PubMed ID: 15558323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of ornithine decarboxylase activity by cyclic AMP in guinea pig lymphocytes: transcriptional and post-transcriptional control.
    Otani S; Kuramoto A; Morisawa S
    Biochim Biophys Acta; 1982 Feb; 696(2):171-8. PubMed ID: 6277383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of decarboxylase inhibition and neuroleptic drugs on the DOPA level in rat brain.
    Cegrell L; Nordgren L; Rosengren AM
    Res Commun Chem Pathol Pharmacol; 1970 Jul; 1(4):479-84. PubMed ID: 4400174
    [No Abstract]   [Full Text] [Related]  

  • 24. The cyclic AMP-mediated action of epinephrine on the activity of carbonic anhydrase in avian erythrocytes.
    Siegmund P; Tüllmann A; Holke M
    Horm Metab Res; 1974 Mar; 6(2):158-61. PubMed ID: 4364017
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].
    Gauthier G; de Ajuriaguerra J; Simona B; Constantinidis J; Eisenring JJ; Krassoievitch M; Yanniotis G; Tissot R
    Rev Neurol (Paris); 1970 Nov; 123(5):297-319. PubMed ID: 5513630
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of parkinsonian syndromes and plasmatic DOPA levels. Effects of L-DOPA and 3-OMD, administered alone or combined, with or without a decarboxylase inhibitor].
    Geissbühler F; Gaillard JM; Eisenring JJ; Krassoievitch M; Yanniotis G; Tissot R
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):38-44. PubMed ID: 5041348
    [No Abstract]   [Full Text] [Related]  

  • 27. Coordinate protein kinase activation and specific enzyme induction by cyclic nucleotide derivatives in intact cultured hepatoma cells.
    Wimalasena J; Wicks WD
    Mol Pharmacol; 1979 Sep; 16(2):449-61. PubMed ID: 42014
    [No Abstract]   [Full Text] [Related]  

  • 28. Induction of translatable mRNA for dopa decarboxylase in Drosophila: an early response to ecdysterone.
    Kraminsky GP; Clark WC; Estelle MA; Gietz RD; Sage BA; O'Connor JD; Hodgetts RB
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4175-9. PubMed ID: 6776524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tepa, shikonin and ecdysone on the alkaline phosphatase in the larvae Aedes aegypti (L.).
    Gorgees NS; Naqvi SN; Rashan LJ; Zakaria SJ
    Folia Histochem Cytochem (Krakow); 1978; 16(1):51-6. PubMed ID: 76599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation of luteinization in rabbit Graafian follicles by dibutyryl cyclic AMP in vitro.
    Miller JB; Keyes PL
    Endocrinology; 1974 Jul; 95(1):253-9. PubMed ID: 4365624
    [No Abstract]   [Full Text] [Related]  

  • 31. Cell-type differences in the serum and cyclic AMP-dependent regulation of ornithine decarboxylase activity in two cultured fibroblast types.
    Boucek RJ; Weiss J; Lembach KJ
    Biochem J; 1982 Apr; 204(1):357-60. PubMed ID: 6180738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dibutyryl cyclic AMP on in vitro rat testis DNA, RNA and protein labeling.
    Hollinger MA; Hwang F
    Endocrinology; 1974 Feb; 94(2):444-9. PubMed ID: 4359128
    [No Abstract]   [Full Text] [Related]  

  • 33. Decrease of the 3,4-dihydroxyphenylalanine (DOPA) decarboxylase activities in human erythrocytes and mouse tissues after administration of DOPA.
    Tate SS; Sweet R; McDowell FH; Meister A
    Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2121-3. PubMed ID: 5289372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic AMP-mediated induction of ornithine decarboxylase of glioma and neuroblastoma cells.
    Bachrach U
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3087-91. PubMed ID: 171652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal aspects of the regulation of dopa decarboxylase in Drosophila melanogaster.
    Hodgetts RB; Clark WC; Eveleth DD; Gietz RD; Spencer CA; Marsh JL
    Prog Clin Biol Res; 1986; 217A():221-34. PubMed ID: 3092244
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of adrenal ornithine decarboxylase by adrenocorticotropic hormone and cyclic AMP.
    Richman R; Dobbins C; Voina S; Underwood L; Mahaffee D; Gitelman ; Van Wyk J; Ney RL
    J Clin Invest; 1973 Aug; 52(8):2007-15. PubMed ID: 4352578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium, asparagine and cAMP are required for ornithine decarboxylase activation in intact Chinese hamster ovary cells.
    Costa M; Nye JS
    Biochem Biophys Res Commun; 1978 Dec; 85(3):1156-64. PubMed ID: 83867
    [No Abstract]   [Full Text] [Related]  

  • 38. Stimulation of sodium transport in turkey erythrocytes by cyclic 3',5'-AMP.
    Gardner JD; Klaeveman HL; Bilezikian JP; Aurbach GD
    Endocrinology; 1974 Aug; 95(2):499-507. PubMed ID: 4369216
    [No Abstract]   [Full Text] [Related]  

  • 39. Specificity of cyclic AMP potentiation of glucose-stimulated insulin release.
    Lernmark A
    Horm Res; 1974; 5(4):227-33. PubMed ID: 4366458
    [No Abstract]   [Full Text] [Related]  

  • 40. Control of ornithine decarboxylase activity by cyclic nucleotides in the phytohemagglutinin induced lymphocyte transformation.
    Mizoguchi Y; Otani S; Matsui I; Morisawa S
    Biochem Biophys Res Commun; 1975 Sep; 66(1):328-35. PubMed ID: 169849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.